Published in Drugs Exp Clin Res on January 01, 1987
Safety of acid-suppressing drugs. Dig Dis Sci (1995) 0.83
Functional gastroduodenal disorders. Gut (1999) 3.74
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
Persistent hepatitis C viraemia without liver disease. Lancet (1993) 3.14
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut (1987) 2.46
Manometric evaluation of functional upper gut symptoms. Gastroenterology (1985) 2.38
Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med (1997) 2.33
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol (2013) 2.21
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci (1989) 2.17
Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med (1998) 2.04
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut (2004) 2.04
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab (1993) 1.94
Enzymatic determination of cholesterol in bile. Clin Chim Acta (1975) 1.88
Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis (2006) 1.85
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther (2009) 1.83
Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology (1991) 1.82
Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology (1989) 1.81
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord (2002) 1.77
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther (1999) 1.76
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord (2003) 1.74
Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest (2003) 1.71
Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease. Hepatology (1989) 1.70
Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol (1998) 1.61
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther (1994) 1.59
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest. Digestion (2004) 1.57
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology (1994) 1.53
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.45
[The role of diffusion 3-Tesla MRI in detecting prostate cancer before needle biopsy: multiparametric study of 111 patients]. J Radiol (2010) 1.43
Diabetic retinopathy in chronic pancreatitis. Gastroenterology (1990) 1.41
Stress-induced gastroduodenal motor disturbances in humans: possible humoral mechanisms. Gastroenterology (1983) 1.40
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol (1994) 1.38
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
Lipid, lipoprotein, and apolipoprotein assessment during an 8-wk very-low-calorie diet. Am J Clin Nutr (1992) 1.37
Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology (1997) 1.36
Assessment of portal hypertension by endoscopic ultrasonography. Gastrointest Endosc (1990) 1.34
New insights into human enteric neuropathies. Neurogastroenterol Motil (2004) 1.31
Acid gastroesophageal reflux and symptom occurrence. Analysis of some factors influencing their association. Dig Dis Sci (1989) 1.30
Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab (1989) 1.29
The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid. Digestion (1976) 1.29
Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther (2001) 1.24
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil (2006) 1.23
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology (1991) 1.20
Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil (2008) 1.20
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet (1989) 1.19
Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology (1985) 1.16
Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? Gastroenterology (1999) 1.16
Diagnostic value of serum primary bile acids in detecting bile acid malabsorption. Gut (1982) 1.16
Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology (1993) 1.13
Value of endoscopic ultrasonography in the management of portal hypertension. Endoscopy (1992) 1.12
Gastric secretion and emptying of liquids in reflex esophagitis. Dig Dis Sci (1981) 1.11
Function of the internal anal sphincter and rectal sensitivity in idiopathic constipation. Digestion (1982) 1.10
Endoscopic ultrasonography in the diagnosis of gastric submucosal tumor. Gastrointest Endosc (1989) 1.10
Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol (1999) 1.09
Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli. Gastroenterology (1984) 1.08
Enterohepatic circulation of bile acids after cholecystectomy. Gut (1978) 1.08
Bile acid malabsorption and bile acid diarrhea in intestinal resection. Dig Dis Sci (1982) 1.06
Interrelationships between body weight, body fat distribution and insulin in obese women before and after hypocaloric feeding and weight loss. Ann Nutr Metab (1989) 1.06
Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci (1994) 1.05
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases. Aliment Pharmacol Ther (1993) 1.03
Morphologic and cytoproliferative patterns of duodenal mucosa in two patients after long-term total parenteral nutrition: changes with oral refeeding and relation to intestinal resection. JPEN J Parenter Enteral Nutr (1994) 1.03
Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res (1990) 1.02
Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Gastroenterology (1991) 1.02
Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations. Br J Pharmacol (2000) 1.02
Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol (1992) 1.02
Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study. J Med Virol (1991) 1.02
Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology (1988) 1.02
Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol (2011) 1.01
Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry. Scand J Gastroenterol (1992) 1.01
Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol (2000) 1.01
Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology (1983) 1.00
A single-specimen fecal chymotrypsin test in the diagnosis of pancreatic insufficiency: correlation with secretin-cholecystokinin and NBT-PABA tests. Am J Gastroenterol (1984) 1.00
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metab (2000) 0.99
Cannabinoid type 1 receptor: another arrow in the adipocytes' bow. J Neuroendocrinol (2008) 0.98
Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol (2000) 0.97